Related Experiment Video
Updated: Jan 22, 2026
07:49
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
1.9K
Updates on the Genetic Paradigm in Heart Failure
Andrew N Rosenbaum1, Naveen Pereira2,3,4
1Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Current Treatment Options in Cardiovascular Medicine
|June 29, 2019
Summary
Recent advances in heart failure genetics improve diagnostic yield and patient care. Genetic testing now offers better prognostic insights and personalized treatment strategies for various cardiomyopathies.
Area of Science:
- Cardiovascular Genetics
- Genomic Medicine
Background:
- Cardiovascular genetics is rapidly advancing, enhancing patient care for heart failure families.
- Understanding genetic underpinnings of heart failure is crucial for improved diagnostics and therapeutics.
Purpose of the Study:
- To review pertinent updates in the field of heart failure genetics.
- To highlight recent advancements in genetic testing and their clinical implications.
Main Methods:
- Review of recent literature on heart failure genetics.
- Analysis of technological advancements in genetic screening (whole exome/genome).
Main Results:
- Improved diagnostic yield through advanced genetic technologies.
- Enhanced understanding of genetic testing implications, including differential therapy responses.
- Better prognostic insights from variant analysis in genetic cardiomyopathies.
- Progress in understanding genetics of rare cardiomyopathies (pediatric, restrictive, non-compaction).
Conclusions:
- Recent years show significant leaps in understanding heart failure genetics, encompassing scope, mechanisms, and prognosis.
- These advancements form the basis for future clinical investigations and genetic variant assessments.
- The integration of genetic insights promises to further personalize heart failure management.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
790
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
790
01:17Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
01:27Heart Failure I: Introduction
729
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
729
01:22Heart Failure VI: Adjunct Therapies
278
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
278
01:22Heart Failure Drugs: Diuretics
825
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
825
01:30Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227